Article ; Online: Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
Journal of medicinal chemistry
2020 Volume 63, Issue 20, Page(s) 11362–11367
Abstract: Outsourcing has become an integral part of how research and early development (R&D) is executed ...
Abstract | Outsourcing has become an integral part of how research and early development (R&D) is executed in biotech companies and large pharmaceutical organizations. Drug discovery organizations can choose from several operational models when partnering with a service provider, ranging from short-term, fee-for-service (FFS)-based arrangements to more strategic full-time-equivalent (FTE)-based collaborations and even risk-sharing relationships. Clients should consider a number of criteria when deciding which contract research organization (CRO) is best positioned to help meet their goals. Besides cost, other factors such as intellectual property protection, problem solving skills, value-creation ability, communication, data integrity, safety and personnel policies, ease of communication, geography, duration of engagement, scalability of capacity, and contractual details deserve proper consideration. In the end, the success of a drug discovery partnership will depend in large part on the people who execute the science. |
---|---|
MeSH term(s) | Contracts/economics ; Contracts/legislation & jurisprudence ; Cooperative Behavior ; Drug Discovery/economics ; Drug Discovery/legislation & jurisprudence ; Drug Discovery/organization & administration ; Efficiency, Organizational ; Intellectual Property ; Models, Organizational ; Outsourced Services/economics ; Outsourced Services/legislation & jurisprudence ; Outsourced Services/organization & administration ; Pharmaceutical Research/economics ; Pharmaceutical Research/legislation & jurisprudence ; Pharmaceutical Research/organization & administration |
Language | English |
Publishing date | 2020-06-18 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 218133-2 |
ISSN | 1520-4804 ; 0022-2623 |
ISSN (online) | 1520-4804 |
ISSN | 0022-2623 |
DOI | 10.1021/acs.jmedchem.0c00176 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 151: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MB 1: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.